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The cognitive deficits observed in children with cyanotic congenital heart disease suggest involvement of the developing hippocampus.
Chronic postnatal hypoxia present during infancy in these children may play a role in these impairments. To understand the biochemical
mechanisms of hippocampal injury in chronic hypoxia, a neurochemical profile consisting of 15 metabolite concentrations and 2 metabolite
ratios in the hippocampus was evaluated in a rat model of chronic postnatal hypoxia using in vivo 1H NMR spectroscopy at 9.4 T. Chronic
hypoxia was induced by continuously exposing rats (n = 23) to 10% O2 from postnatal day (P) 3 to P28. Fifteen metabolites were quantified
from a volume of 9–11 Al centered on the left hippocampus on P14, P21, and P28 and were compared with normoxic controls (n = 14). The
developmental trajectory of neurochemicals in chronic hypoxia was similar to that seen in normoxia. However, chronic hypoxia had an effect
on the concentrations of the following neurochemicals: aspartate, creatine, phosphocreatine, GABA, glutamate, glutamine, glutathione, myo-
inositol, N-acetylaspartate (NAA), phosphorylethanolamine, and phosphocreatine/creatine (PCr/Cr) and glutamate/glutamine (Glu/Gln) ratios
(P b 0.001 each, except glutamate, P = 0.04). The increased PCr/Cr ratio is consistent with decreased brain energy consumption. Given the
well-established link between excitatory neurotransmission and brain energy metabolism, we postulate that elevated glutamate, Glu/Gln ratio,
and GABA indicate suppressed excitatory neurotransmission in an energy-limited environment. Decreased NAA and phosphorylethanol-
amine suggest reduced neuronal integrity and phospholipid metabolism. The altered hippocampal neurochemistry during its development
may underlie some of the cognitive deficits present in human infants at risk of chronic hypoxia.
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The incidence of cyanotic congenital heart disease
(CHD) is approximately 2 per 1000 live births [22]. While
advances in the techniques of cardiopulmonary bypass and
hypothermia have improved the survival rates of these
infants [31], cognitive deficits remain a significant cause of
morbidity in this population [6]. Developmental delay hasch 156 (2005) 202–209
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CHD [1]. In children with CHD, long-term studies using
standardized tests of academic achievement have demon-
strated lower scores compared with the controls [54].
Multiple risk factors such as chronic hypoxia, anesthesia,
and potentially low cerebral blood flow during cardiopul-
monary bypass may be responsible for these learning
disabilities [35–37].
Children with CHD are in a state of chronic hypoxia
prior to the repair of their cardiac lesion. Most surgical
repairs for CHD are performed during the first 2 to 3 years
of life [47], and therefore, the time period of chronic
hypoxia encompasses the period of rapid hippocampal
growth and development [4]. The hippocampus is central
to recognition memory and plays an important role in
cognitive development. Early hippocampal damage due to
chronic hypoxia may lead to memory deficits, which could
present as learning disabilities in children with CHD.
In rats, the rapid phase of hippocampal development
occurs postnatally in the first 4 weeks and corresponds to
the first two to three postnatal years of rapid hippocampal
development in humans [4]. Rodents that have been hypoxic
during the early postnatal period demonstrate evidence of
disrupted synaptic development [13], alterations in NMDA
receptor expression and function [42], and alterations in key
enzymes of glucose oxidative metabolism in the brain [26].
The activity of neuronal cytochrome c oxidase, a key
enzyme in oxidative phosphorylation, is decreased in
chronic hypoxia [11,27].
Given the effects of chronic hypoxia on brain energy
metabolism and neurotransmitter function, a longitudinal
evaluation of neurochemical changes during hippocampal
development may aid in the understanding of the
potential mechanisms by which chronic hypoxia alters
hippocampal development and function. In vivo high-
field 1H NMR spectroscopy is a sensitive and non-
invasive method that can be used for the simultaneous
quantification of multiple metabolites from distinct
regions of the developing brain under physiological and
adverse perinatal conditions [46,50]. At high magnetic
field strengths of 9.4 T, a neurochemical profile
consisting of metabolite markers of energy metabolism,
neuronal integrity, myelination, and neurotransmitters can
be reliably and longitudinally measured from specific
brain regions, such as the developing hippocampus
[46,50].
The objective of the present study was to evaluate in
vivo the hippocampal neurochemical profile in a rat
model of chronic postnatal hypoxia. We hypothesized that
chronic hypoxia would adversely affect the metabolite
markers of energy metabolism, neuronal integrity, myeli-
nation, and neurotransmitters. We used a well-described
rodent model of chronic postnatal hypoxia in our study
[11,26,32]. Rats between the ages of postnatal day (P) 14
and P28 were studied because of the similarity between
their hippocampal development and that of, respectively,a full-term human newborn infant and a 2- to 3-year-old
child [4].2. Materials and methods
2.1. Animal preparation
The study was approved by and performed according to
the guidelines of the Institutional Animal Care and Use
Committee at the University of Minnesota. Pregnant
Sprague–Dawley rats were purchased (Harlan Sprague–
Dawley; Indianapolis, IN) and housed with free access to
food and water in the local animal care facility. The dams
and the pups were maintained on a regular diet (Teklad 4%
Mouse/Rat Diet 7001, Harlan-Teklad; Madison, WI). On
P3, the pups were randomly culled to eight per litter to
ensure adequate nutrition. Twenty-three pups from three
litters were studied by 1H NMR spectroscopy. Thirteen pups
were studied longitudinally at all three time points, and the
rest were studied in a cross-sectional manner, resulting in
16–17 spectra at each of the three postnatal ages. The
neurochemical profile during development was compared
with our previously published data of normoxic controls
[50]. Historical controls were used because of the expense
of performing the studies and the precision of the metabolite
concentrations generated in that study. Briefly, the data of
the normoxic controls had been obtained from fourteen age-
matched rats from three litters that were raised under
conditions identical to the chronic hypoxia group, except
for the O2 concentration in the environment (21% instead of
10%). Seven of these rats were studied by 1H NMR
spectroscopy at each of the three postnatal ages, and the
remaining rats were studied in a cross-sectional manner,
resulting in 8–11 spectra at each of the three postnatal ages.
A separate set of pups in the chronic hypoxia (n = 12 from
two litters) and normoxia groups (n = 16 from two litters)
were used for measurement of body and brain weights, brain
water content and hematocrit on P14 and P28, and brain iron
concentration on P14.
2.2. Induction of postnatal chronic hypoxia
The dam and the pups in the chronic hypoxia group were
subjected to continuous postnatal hypoxia from P3 to P28.
They were placed in an airtight Plexiglas chamber (Scien-
tific Apparatus; University of Minnesota; Minneapolis,
MN). The concentration of O2 inside the chamber was
maintained at 10% by mixing air and nitrogen and was
monitored using an oxygen analyzer (Miniox II; Catalyst
Research Corporation; Owings Mills, MD). The degree of
hypoxia was based on rodent models of CHD [8,34]. Excess
humidity from the chamber was eliminated using calcium
bisulphate (Drierite; W.A. Hammond Drierite Company;
Xenia, OH). The chamber was opened for maintenance
twice a week for approximately 10 min each time. The rats
Table 1
Effect of postnatal chronic hypoxia on body weight, brain weight,
hematocrit, brain iron concentration, and brain water content of the
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and light cycle.
2.3. 1H NMR spectroscopy
Spontaneously breathing rat pups were studied using 1H
NMR spectroscopy on P14, P21, and P28 under inhalation
anesthesia using previously published methods from our
laboratory [46,50]. The mean F SD duration of anesthesia
was 56 F 8 min on P14, 49 F 5 min on P21, and 48 F 5
min on P28. The mean total duration that the animals were
removed from the hypoxia chamber for 1H NMR spectro-
scopy was 125 F 6 min on P14 and 110 F 6 min on P21.
P28 animals were maintained in normoxia after the
conclusion of the study. A uniform temperature was
maintained inside the magnet using circulating warm water.
In order to assess whether acutely placing the rats in 50%
O2 during NMR studies altered markers of energy metab-
olism, P28 pups from the chronic hypoxia group (n = 6)
underwent 1H NMR spectroscopy under both 50% O2 and
10% O2. Additionally, to evaluate whether repeated
exposure to normoxia and anesthesia had affected the
neurochemical profile, four animals from a litter in the
chronic hypoxia group were studied longitudinally at all
three postnatal ages and their four littermates were studied
only on P28.
All experiments were performed on a 9.4 T/31 cm
magnet (Magnex Scientific; Abingdon, U.K.) equipped with
11 cm gradient coil (300 mT/m, 500 As) and custom-
designed shim coil (Magnex Scientific; Abingdon, U.K.)
with second-order shim strength up to 0.04 mT/cm2 [51].
The magnet was interfaced with a Varian INOVA console
(Varian, Inc.; Palo Alto, CA). A quadrature transmit/receive
surface RF coil with two geometrically decoupled single-
turn coils was used. Homogeneity of the magnetic field was
automatically adjusted by FASTMAP shimming [15,17].
The water signal was suppressed by VAPOR method [49]
and localization was done by ultra-short echo-time STEAM
(TE = 2 ms, TM = 20 ms, TR = 5 s) combined with outer
volume suppression. The positions of volume of interest
(VOI) 9–11 Al were centered on the left hippocampus based
on multislice RARE images.developing rats
Postnatal
age (days)
Chronic
hypoxia group
Normoxia
group
P
Body weight (g) 14 23.5 F 2.6 32.5 F 2.1 b0.001
28 61.1 F 5.0 97.5 F 11.0 b0.001
Brain weight (g) 14 0.70 F 0.06 0.86 F 0.06 b0.001
28 0.73 F 0.03* 1.14 F 0.03 b0.001
Hematocrit (%) 14 45.0 F 2.8 40.0 F 1.7 0.001
28 65.1 F 3.1 39.3 F 1.4 b0.001
Brain iron
concentration
(Ag/g)
14 6.3 F 1.0 8.2 F 1.1 0.004
Brain water
content (%)
14 82 85 0.014
28 80* 80 NS
Values: mean F SD (n = 8/group at each age, except *n = 4).
Significance by two-tailed unpaired t test.3. Analysis
3.1. Quantitation of metabolites
1H NMR spectra were analyzed using LC Model [43],
including a macromolecule spectrum in the database,
according to previously described procedures [41,50]. The
unsuppressed water signal from the same VOI and age-
dependent brain water content were used for metabolite
quantification. The brain water content was measured on
P14 and P28 using the weight difference between freshly
removed brain and its residue after lyophilization. Thefollowing 18 metabolites were quantified from each
spectrum: alanine, aspartate, creatine (Cr), g-aminobutyric
acid (GABA), glucose, glutamate, glutamine, glutathione,
glycerophosphorylcholine (GPC), lactate, myo-inositol, N-
acetylaspartate (NAA), N-acetylaspartylglutamate, phos-
phocreatine (PCr), phosphorylcholine (PCho), phosphoryle-
thanolamine, scyllo-inostol, and taurine.The phosphocreatine/
creatine (PCr/Cr) and glutamate/glutamine (Glu/Gln) ratios
were calculated.
3.2. Brain iron assay
Animals were deeply anesthetized with sodium pento-
barbital (120 mg/kg IP) and blood samples for hematocrit
were taken from the left ventricle. Following in situ
transcardial perfusion with normal saline, the brain was
dissected out, flash-frozen and stored at 80 8C. Brain iron
concentration was assayed by atomic absorption spectro-
scopy [45] and was expressed as Ag of elemental iron/g wet-
tissue weight.
3.3. Statistical analysis
Group means of body weight, brain weight, brain water
content, and hematocrit on P14 and P28, and brain iron
concentration on P14 in the two groups were compared
using the two-tailed unpaired t test. The effects of age,
chronic hypoxia and age-dependent effect of chronic
hypoxia (age * chronic hypoxia) on the metabolites were
determined using multivariate analysis of variance (MAN-
OVA). For metabolites that demonstrated a difference, the
age-specific effect of chronic hypoxia was determined by
performing post hoc analyses using the Bonferroni-adjusted
t test at each postnatal age. A software package (SPSS;
Chicago, IL) was used for the statistical analysis. The data
are presented as mean F SD. Statistical significance was set
at P b 0.05, except for the post hoc analyses, where
significance was set at P b 0.02.
L. Raman et al. / Developmental Brain Research 156 (2005) 202–209 2054. Results
The pups in the chronic hypoxia group had lower body
and brain weights and higher hematocrits when compared
with the normoxia group on P14 and P28. The mean brain
water content and brain iron concentration on P14 were
lower in the chronic hypoxia group (Table 1).
Representative in vivo 1H NMR spectra from the
hippocampus of chronic hypoxia and normoxia rats, and
the corresponding MR images with selected VOI are
displayed in Fig. 1. In addition to signals typical for clinical
1H NMR spectra (NAA, Cr, choline), signals of other
metabolites, such as aspartate, glutamate, myo-inositol, N-
acetylaspartylglutamate, and taurine, could be readilyFig. 1. MRI and 1H NMR spectra from the hippocampus of chronic hypoxia (Pane
(A: 2.5  1.3  3.0 mm3; B: 2.5  1.5  3.0 mm3) is placed on the left hippocam
spectral regions (3.8 to 4.1 ppm) demonstrating signals of creatine and phosphoc
Abbreviations. Asp: aspartate, Cr: creatine, GABA: g-aminobutyric acid, Glu: glu
myo-inositol, NAA: N-acetylaspartate, NAAG: N-acetylaspartylglutamate, PCr: ph
Tau: taurine.identified. In addition, signals of the methylene groups of
Cr and PCr were resolved (insets in Fig. 1). Fifteen of
eighteen metabolites included in the LC Model basis set
were reliably quantified (Cramer-Rao lower bounds
[CRLB], b25%) from each spectrum and only these were
used for further analysis. Alanine and scyllo-inositol were
excluded due to CRLB N 25%. Furthermore, because of
strong cross-correlation between GPC and PCho, due to
their close spectral similarity, the sum of GPC and PCho
was analyzed.
To verify whether multiple exposures to anesthesia and
50% O2 concentration during NMR experiments com-
pounded the effects of chronic hypoxia on metabolites,
metabolite concentrations on P28 from four pups studiedl A) and normoxia (Panel B) rat on postnatal day 14. The volume of interest
pus from where 1H NMR spectra were obtained. Insets show the expanded
reatine. Localization sequence: STEAM, TE = 2 ms, TR = 5 s, NT = 240.
tamate, Gln: glutamine, GPC: glycerophosphorylcholine, Lac: lactate, Ins:
osphocreatine, PCho: phosphorylcholine, PE: phosphorylethanolamine and
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those obtained from the four littermates that were studied
only on P28. No significant differences were present for any
metabolite (Fig. 2). Thus, the data from animals studied
longitudinally and cross-sectionally were pooled together to
establish the mean values at each postnatal age.
In both groups, there were developmental changes
between P14 and P28 in the concentrations of all
metabolites, except glucose and lactate (P b 0.003 each).
The developmental trajectories of metabolites in the chronic
hypoxia group were similar, but not identical, to those in the
normoxia group. Chronic hypoxia had an effect on Cr,
GABA, glutamine, myo-inositol, NAA, and phosphoryle-
thanolamine concentrations, as well as on PCr/Cr and Glu/
Gln ratios (P b 0.001 each, Fig. 3). Aspartate, PCr,
glutamate, and glutathione concentrations were also affected
by chronic hypoxia (P b 0.001 each, except glutamate P =
0.04; data not shown). Chronic hypoxia had no effect on
taurine (Fig. 3), glucose, GPC + PCho, lactate and N-
acetylaspartylglutamate concentrations (data not shown).
Chronic hypoxia had an age-dependent effect (age * chronic
hypoxia) on aspartate, PCr, glutamate, myo-inositol, NAA,
phosphorylethanolamine concentrations, and PCr/Cr ratio
(P b 0.001 each, except PCr/Cr ratio P = 0.03).
To determine whether the elevated PCr/Cr ratio resulted
from acute exposure to higher O2 concentration during the
NMR studies, 1H NMR spectra were obtained in six P28
pups under both 50% O2 and 10% O2. Exposure to 10% O2
resulted in increased spectral line-width and decreasedFig. 2. Neurochemical concentrations in the hippocampus of postnatal day (P) 28 r
were studied on all three postnatal days (P14, P21, and P28); Cross-sectional repr
mean F SD; n = 4 in each group (P not significant; two-tailed unpaired t test). Ab
glucose, Glu: glutamate, Gln: glutamine, GSH: glutathione, GPC: glycerophospho
N-acetylaspartylglutamate, PCr: phosphocreatine, PCho: phosphorylcholine, PE:accuracy of Cr and PCr quantification (CRLB increased
from 6% to 15%). In spite of this, PCr/Cr ratio was elevated
at 10% O2 concentration and was similar to that measured
using 50% O2 concentration (P = 0.14).5. Discussion
Chronic hypoxia significantly altered the neurochemical
profile of the developing rat hippocampus. Ten of the fifteen
neurochemicals were affected as a result of exposure to
chronic hypoxia, while five were spared. Such differential
effects on metabolites in the hippocampus suggest that
certain biochemical pathways are more sensitive than others
to chronic hypoxia. Alterations in energy metabolism by
chronic hypoxia may underlie many of the neurochemical
changes.
The most intriguing effect of chronic hypoxia was on
energy metabolism, as indexed by the elevated PCr/Cr ratio.
We expected the PCr/Cr ratio to be reduced because
cytochrome c oxidase activity is decreased in chronic
hypoxia [11,27] and because PCr acts as a temporary
energy buffer when ATP production is inadequate [52].
Furthermore, the effect was present during both hypoxic
conditions and hyperoxic testing states, suggesting that the
increase was due to chronic hypoxia rather than to the
sudden hyperoxic conditions during NMR studies.
The increased PCr/Cr ratio in the presence of decreased
oxidative phosphorylation suggests that energy metabolismats in the chronic hypoxia group. Longitudinal represents data from rats that
esents data from littermates that were studied only once on P28. Values are
breviations. Asp: aspartate, Cr: creatine, GABA: g-aminobutyric acid, Glc:
rylcholine, Lac: lactate, Ins: myo-inositol, NAA: N-acetylaspartate, NAAG:
phosphorylethanolamine and Tau: taurine.
Fig. 3. Effect of chronic hypoxia on creatine, N-acetylaspartate (NAA), glutamine, g-aminobutyric acid (GABA), myo-inositol, phosphorylethanolamine, and
taurine concentrations, and phosphocreatine/creatine (PCr/Cr) and glutamate/glutamine (Glu/Gln) ratios during hippocampal development in the chronic
hypoxia and normoxia groups. Values are mean F SD; n = 23 in the chronic hypoxia group and n = 14 in the normoxia group. The normoxia data are from a
previously published study [50]. There were developmental changes between postnatal days 14 and 28 in all metabolites ( P b 0.03 each). 1Metabolites affected
by chronic hypoxia and 2metabolites affected by age * chronic hypoxia, respectively ( P b 0.001 each; MANOVA). Asterisks denote significant differences
between groups at each postnatal age (*P b 0.02, **P b 0.001, and ***P b 0.0001; Bonferroni-adjusted unpaired t test).
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response. We propose that the developing hippocampus
adapts to chronic hypoxia by decreasing its energy
utilization. Reduced energy utilization has been documented
in neuronal cell cultures in response to acute hypoxia [33]
and in certain highly anoxia-tolerant species, such as turtles
and fish [21]. Furthermore, it has been demonstrated that
PCr concentration increases in the rat brain when cerebral
energy consumption is suppressed by the ingestion of ethyl
alcohol [14]. It is likely that chronic hypoxia in our model
may have induced a similar effect on PCr.
Understanding altered hippocampal energy metabolism
during chronic hypoxia is important because it may account
for the increased glutamate and GABA concentrations, and
Glu/Gln ratio in the chronic hypoxia group. These neuro-
transmitter findings imply that excitatory neurotransmission
may be suppressed in chronic hypoxia. Glutamate plays an
important role in synaptogenesis and plasticity through the
stimulation of NMDA receptors [2,20,25]. Glutamate-mediated excitatory neurotransmission is a metabolically
expensive process [3] and is predominantly accomplished
through glutamate–glutamine cycling between neurons and
astrocytes [16,18,30]. As 1H NMR spectroscopy measures
glutamate predominantly in the neuronal compartment [38],
increased glutamate in our study implies that glutamate
release from the neurons may be suppressed in chronic
hypoxia, presumably in an attempt to conserve the meager
energy stores [19]. The decreased expression of NMDA
receptors and disrupted hippocampal synaptogenesis dem-
onstrated in this model support our postulation [13,42].
The energy findings also were potentially responsible for
the elevation of GABA concentration, a finding previously
described in this model [53]. Depletion of ATP due to
hypoxia results in increased synthesis and decreased
catabolism of GABA in hippocampal neurons [29]. Ele-
vated GABA concentration in our study is consistent with
the premise that the overall excitatory activity of the neurons
is suppressed in chronic hypoxia. For example, in patients
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the brain suppresses brain activity and results in improved
seizure control [39]. We speculate that increased GABA
levels may provide such an inhibitory drive against
excitatory neurotransmission in chronic hypoxia.
Changes in phosphorylethanolamine and NAA concen-
trations also may be due to altered energy metabolism in
chronic hypoxia. Phosphorylethanolamine, a precursor of
the major brain phospholipid phosphatidylethanolamine
[44], was lower in the chronic hypoxia group. In humans
and rats, the levels of phosphorylethanolamine are initially
high and decrease with the onset of myelination [9,40].
There also is evidence to suggest that phosphorylethanol-
amine levels are increased in tumors of the brain that have
high cell turnover rates [23]. We postulate that the decreased
phosphorylethanolamine levels demonstrated in our study
are due to altered myelination or decreased cell turnover in a
hypometabolic state.
NAAwas reduced in the chronic hypoxia group. NAA is
synthesized and stored primarily in the neuron and has long
been considered a marker of neuronal integrity in the adult
brain [5]. However, the role of NAA in the developing brain
is not well described. Even though NAA is produced in
neurons, its catabolic enzyme, aspartoacylase, is found
primarily in oligodendrocytes [5,7,10]. Deacetylation of
NAA contributes carbons to fatty acid synthesis during
myelin generation [24], a highly energy-dependent process
in the developing brain. Studies have demonstrated that the
rate of deposition, quantity and maturation of myelin are
delayed in chronic hypoxia [28,32]. Decreased NAA in the
present study may therefore represent loss of neuronal
integrity, altered myelination, or both in chronic hypoxia.
The animal model used in this study is well described for
studies of chronic hypoxia and results in a similar degree of
hypoxia present in human infants with CHD [8,26,32]. The
body weight of the chronic hypoxia rats was decreased, as has
been demonstrated in all studies that have used a similar
model [8,12,26]. While the associated malnutrition may have
played a role in the neurochemical alterations, the effects are
likely to be minor. In a rat model of malnutrition with similar
loss of body weight, there were no alterations in PCr, and
glutamate levels were decreased in the brain [48]. Similarly,
as seen in children with CHD, iron deficiency was present in
the chronic hypoxia group. While the 20% reduction in brain
iron concentration may have played a role in the neuro-
chemical alterations, it is unlikely to be responsible for all the
changes. While changes in certain neurochemicals (for
example, PCr/Cr, glutamate, and GABA) were similar in
the two conditions, those in others (such as NAA and
phosphorylethanolamine) were distinctly different from
those demonstrated in perinatal iron deficiency [46].
In conclusion, the neurochemical profile of the develop-
ing hippocampus was altered in chronic hypoxia. Changes
in multiple metabolites suggest involvement of several
biochemical pathways consistent with adaptive changes to
altered energy metabolism in chronic hypoxia. High-field1H NMR spectroscopy allowed us to longitudinally and
comprehensively study these neurochemical changes.
Because it is non-invasive, this method can be used in
human infants at risk for chronic hypoxia. Altered hippo-
campal neurochemistry during its phase of rapid develop-
ment may underlie some of the cognitive deficits described
in human infants with chronic hypoxia.Acknowledgments
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